SVV-012

N/A

Report date: 2023/02/10 15:12:26

Base Information

Drug NameSVV-012
Drug Alias NameSVV-001/Anti-PD-LlSVV-012
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionCell death stimulantsProgrammed cell death protein 1 blockersAntibody-dependent cell-mediated cytotoxicity (ADCC) effects +[4] 
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeneca Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeneca Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A